Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTNNB1 | P35222 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9244302 | 0.96 | CTNNB1 (0.62) | CTNNB1SMN1; SMN2RAB9AALDH1A1L3MBTL1 | |
| SCHEMBL9243804 | 0.96 | CTNNB1 (0.62) | CTNNB1SMN1; SMN2RAB9AALDH1A1L3MBTL1 | |
| SCHEMBL9325745 | 0.89 | CTNNB1 (0.54) | CTNNB1SMN1; SMN2RAB9AALDH1A1L3MBTL1 | |
| SCHEMBL3357655 | 0.87 | ALDH1A1 (0.52) | CTNNB1SMN1; SMN2ALDH1A1TDP1HTT | |
| SCHEMBL9244300 | 0.85 | CTNNB1 (0.54) | CTNNB1SMN1; SMN2RAB9AALDH1A1L3MBTL1 | |
| SCHEMBL1683907 | 0.85 | CTNNB1 (0.54) | CTNNB1SMN1; SMN2RAB9AALDH1A1L3MBTL1 | |
| SCHEMBL923513 | 0.84 | CTNNB1 (0.53) | CTNNB1SMN1; SMN2RAB9AALDH1A1L3MBTL1 | |
| SCHEMBL466194 | 0.83 | CTNNB1 (0.71) | CTNNB1SMN1; SMN2RAB9AALDH1A1L3MBTL1 | |
| SCHEMBL1798 | 0.83 | CTNNB1 (0.71) | CTNNB1SMN1; SMN2RAB9AALDH1A1L3MBTL1 | |
| SCHEMBL4880275 | 0.83 | AKR1C3 (0.49) | CTNNB1SMN1; SMN2HPGDMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117510338-A | Natural naphthoquinone derivative and preparation method and application thereof | 贵州大学 | 2024-02-06 | — | — | CN | claimed |
| CN-117105897-A | HNO donor compound and preparation method thereof | 海南大学 | 2023-11-24 | — | — | CN | claimed |
| CN-117105826-A | HNO-releasable compound and preparation method thereof | 海南大学 | 2023-11-24 | — | — | CN | claimed |
| EP-0257374-A1 | Phenoxybenzoic-acid derivatives | BAYER AG (DE) | 1988-03-02 | — | — | EP | claimed |
| EP-0030676-B1 | DERIVATIVES OF PHENOXYBENZOIC ACID, PROCESS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND AS PLANT GROWTH REGULATORS | BAYER AG (DE) | 1984-02-08 | — | — | EP | claimed |
| CN-117510338-A | Natural naphthoquinone derivative and preparation method and application thereof | 贵州大学 | 2024-02-06 | — | — | CN | disclosed |
| CN-117105826-A | HNO-releasable compound and preparation method thereof | 海南大学 | 2023-11-24 | — | — | CN | disclosed |
| CN-117105897-A | HNO donor compound and preparation method thereof | 海南大学 | 2023-11-24 | — | — | CN | disclosed |
| EP-2697206-B1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | ATIR HOLDING S A (LU) | 2019-04-03 | — | — | EP | disclosed |
| EP-2697206-B1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | ATIR HOLDING S A (LU) | 2019-04-03 | — | — | EP | disclosed |
| US-20180282336-A1 | Active Acrylamides | SANDOZ AG (CH) | 2018-10-04 | — | — | US | disclosed |
| US-20170327504-A1 | Synthesis of Substituted 1H-Pyrazolo[3,4-D]Pyrimidines | SANDOZ AG (CH) | 2017-11-16 | — | — | US | disclosed |
| US-4155905-A | 6-Substituted penicillanic acid and derivatives thereof | E. R. SQUIBB & SONS, INC. (US) | 1979-05-22 | — | — | US | disclosed |
| US-4077967-A | 6-Substituted penicillanic acid and derivatives thereof | E. R. SQUIBB & SONS, INC. (US) | 1978-03-07 | — | — | US | disclosed |
| US-4061629-A | 6-Amino-6-arylthio penicillanic acids and derivatives thereof | E. R. SQUIBB & SONS, INC. (US) | 1977-12-06 | — | — | US | disclosed |
| US-4061851-A | 7-Amino-7-arylthio cephalosporins | E. R. SQUIBB & SONS, INC. (US) | 1977-12-06 | — | — | US | disclosed |
| US-4029669-A | 6-Benzalimino-6-arylthio penicillanic acids and derivatives thereof | E. R. SQUIBB & SONS, INC. (US) | 1977-06-14 | — | — | US | disclosed |
| US-4026886-A | 7-Acyl-7-arylthiocephalosporins | E. R. SQUIBB & SONS, INC. (US) | 1977-05-31 | — | — | US | disclosed |
| US-3965093-A | 6-Arylthio penicillanic acid and derivatives thereof | E. R. SQUIBB & SONS, INC. (US) | 1976-06-22 | — | — | US | disclosed |
| US-3954744-A | ANTIBACTERIAL | E. R. SQUIBB & SONS, INC. (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180282336-A1 | Active Acrylamides | BTK, SYK, LYN | CTNNB1 2332/4885SMN1; SMN2 4473/4885RAB9A 4205/4885 |
| US-20170327504-A1 | Synthesis of Substituted 1H-Pyrazolo[3,4-D]Pyrimidines | BTK, ABL1, SYK | CTNNB1 1718/4885SMN1; SMN2 4617/4885RAB9A 3357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.